Provided by Tiger Trade Technology Pte. Ltd.

ANI Pharmaceuticals

71.45
-0.0100-0.01%
Volume:5K
Turnover:346.18K
Market Cap:1.64B
PE:15.74
High:71.53
Open:71.53
Low:71.13
Close:71.46
52wk High:99.39
52wk Low:69.96
Shares:22.97M
Float Shares:20.28M
Volume Ratio:0.25
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.54
EPS(LYR):3.32
ROE:20.46%
ROA:5.45%
PB:2.75
PE(LYR):21.52

Loading ...

ANI Pharmaceuticals initiated with an Outperform at Leerink

TIPRANKS
·
Sep 09

U.S. Research Roundup-Argan, Mastec, Oracle

Reuters
·
Sep 09

ANI Pharma SVP, CFO Stephen P. Carey Sells 2,850 Shares for $207,480

Reuters
·
Sep 02

ANI Pharmaceuticals Director Henry O. Gosebruch Files Initial Beneficial Ownership Statement (Form 3)

Reuters
·
Aug 28

How Investors Are Reacting To ANI Pharmaceuticals (ANIP) Board Shake-Up And Strategic Expertise Addition

Simply Wall St.
·
Aug 27

ANI Pharma CEO Nikhil Lalwani Disposes of 5,400 Common Shares Worth $401,220

Reuters
·
Aug 27

ANI Pharmaceuticals (ANIP) Gets a Buy from Barclays

TIPRANKS
·
Aug 26

ANI Pharmaceuticals reshapes board to advance rare disease strategy

TIPRANKS
·
Aug 24

A Quiet Monday: What Wall Street Didn't File

FilingAlpha
·
Aug 24

ANI Pharma Appoints Henry Gosebruch to Board of Directors

Reuters
·
Aug 24

ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors

THOMSON REUTERS
·
Aug 24

ANI Pharma General Counsel Meredith Cook Sells 500 Shares for $37,740

Reuters
·
Aug 14

ANI Pharma SVP, Generics Ori Gutwerg Reports Sale of 3,162 Common Shares Worth $243,474

Reuters
·
Aug 12

These Analysts Slash Their Forecasts On ANI Pharmaceuticals After Q2 Results

Benzinga Earnings
·
Aug 10

ANI Pharmaceuticals is Maintained at Hold by Canaccord Genuity

Dow Jones
·
Aug 10

J.P. Morgan Sticks to Its Buy Rating for ANI Pharmaceuticals (ANIP)

TIPRANKS
·
Aug 10

ANI Pharmaceuticals price target lowered to $119 from $124 at Guggenheim

TIPRANKS
·
Aug 10

Tonix Q2 Revenue Rises Sharply on Tonmya Launch

Reuters
·
Aug 10

Axsome Therapeutics Q2 Revenue Rises on Auvelity Growth

Reuters
·
Aug 10

Veru Q3 Net Loss Narrows on Lower G&A Expenses

Reuters
·
Aug 10